Q2 2021 Earnings

Latest Events

Investor Relations

Press Releases

05 Aug '21
Second quarter GAAP diluted EPS of $0.15 ; non-GAAP diluted EPS of $0.23 , up 35% year-over-year Generated $69 million of cash flow from continuing operations and $51 million of free cash flow in the second quarter Increasing 2021 outlook for Adjusted EBITDA and free cash flow CHICAGO --(BUSINESS
22 Jul '21
CHICAGO --(BUSINESS WIRE)--Jul. 22, 2021-- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended June 30, 2021 after the close of stock market hours on Thursday, August 5, 2021 . Allscripts management plans to host a conference call and

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Stephen Shulstein
Vice President, Investor Relations
Stephen.Shulstein@allscripts.com